Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 4

Review Article

Efficacy of Danshen Class Injection in the Treatment of Acute Cerebral Infarction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 4

Results of the network meta-analysis of the fibrinogen (lower left quarter).

A

-0.25
(-0.91, 0.40)
B

0.01
(-0.40, 0.44)
0.27
(-0.39, 0.93)
C

-1.09
(-1.37, -0.80)
-0.83
(-1.45, -0.22)
-1.10
(-1.43, -0.78)
D

-0.36
(-0.92, 0.21)
-0.10
(-0.74, 0.53)
-0.37
(-0.94, 0.21)
0.73
(0.18, 1.29)
E

-1.13
(-1.95, -0.29)
-0.88
(-1.92, 0.18)
-1.14
(-2.06, -0.22)
-0.04
(-0.91, 0.83)
-0.77
(-1.77, 0.24)
F

-0.44
(-0.98, 0.10)
-0.19
(-1.05, 0.66)
-0.45
(-1.14, 0.23)
0.65
(0.03, 1.26)
-0.08
(-0.87, 0.69)
0.69
(-0.31, 1.65)
G

-1.79
(-3.51, -0.06)
-1.54
(-3.39, 0.32)
-1.8
(-3.58, -0.02)
-0.70
(-2.45, 1.06)
-1.43
(-3.25, 0.39)
-0.66
(-2.58, 1.27)
-1.35
(-3.14, 0.47)
H

A: WM; B: Danshen injection + WM; C: Fufang Danshen injection + WM; D: Danhong injection + WM; E: Danshenchuanxiongqin injection + WM; F: Sodium Tanshinone IIA Sulfonate injection + WM; G: Salvianolate injection + WM; H: Danshen Salvianolic Acids injection + WM. The result underlined meant it had statistical significant.